Chlorproethazine
Appearance
![]() | |
Names | |
---|---|
Preferred IUPAC name
3-(2-Chlorophenothiazin-10-yl)-N,N-diethylpropan-1-amine | |
Other names
RP-4909
| |
Identifiers | |
3D model (
JSmol ) |
|
ChEMBL | |
ChemSpider | |
ECHA InfoCard
|
100.001.373 |
KEGG | |
PubChem CID
|
|
UNII | |
CompTox Dashboard (EPA)
|
|
| |
SMILES
| |
Properties | |
C19H23ClN2S | |
Molar mass | 346.91732 g/mol |
Pharmacology | |
N05AA07 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chlorproethazine, sold under the brand name Neuriplege, is a
Synthesis
Chlorproethazine can be synthesized from a diphenylsulfide derivative. The general scheme is sufficiently flexible to permit the interchange of the order of some of the steps.

Thus alkylation of 2-(2-bromo-phenylsulfanyl)-5-chloro-aniline [105790-02-1] (1) with 3-chloro-1-diethylaminopropane [104-77-8] (2) leads to the intermediate (3). Ring closure as above by nucleophilic aromatic displacement leads to the antipsychotic drug chlorproethazine (4).
The last step uses copper powder and is a form of the
Goldberg reaction
).
References
- ISBN 978-1-4757-2085-3.
- ISBN 978-3-88763-075-1.
- ISBN 978-94-011-4439-1.
- ISBN 978-0-8155-1856-3.
- ^ "Chlorproethazine". Drugs.com. Archived from the original on 27 September 2017.
- ISBN 978-1-55009-378-0.
- ISBN 978-3-642-03827-3.
- ^ US 2769002, Buisson P, Gailliot P, "Preparation of Phenothiazine Compounds", issued 30 October 1956, assigned to Rhône-Poulenc